NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE79987 Query DataSets for GSE79987
Status Public on Sep 09, 2016
Title MiR-196b is epigenetically silenced during the pre-malignant stage of lung carcinogenesis
Organism Homo sapiens
Experiment type Expression profiling by array
Summary MicroRNA silencing by promoter hypermethylation may represent a mechanism by which lung cancer develops and progresses, but the microRNAs involved during malignant transformation are unknown. We previously established a model of pre-malignant lung cancer wherein we treated human bronchial epithelial cells (HBEC) with low doses of tobacco carcinogens. Here, we demonstrate that next-generation sequencing of carcinogen-transformed HBECs treated with the demethylating agent 5-aza-2'deoxycytidine revealed miR-196b and miR-34c-5p to be epigenetic targets. Bisulfite sequencing confirmed dense promoter hypermethylation indicative of silencing in multiple malignant cell lines and primary tumors. Chromatin immunoprecipitation studies further demonstrated an enrichment in repressive histone marks on the miR-196b promoter during HBEC transformation. Restoration of miR-196b expression by transfecting transformed HBECs with specific mimics led to cell cycle arrest mediated in part through transcriptional regulation of the FOS oncogene, and miR-196b re-expression also significantly reduced the growth of tumor xenografts. Luciferase assays demonstrated that forced expression of miR-196b inhibited the FOS promoter and AP-1 reporter activity. Finally, a case-control study revealed that methylation of miR-196b in sputum was strongly associated with lung cancer (OR = 4.7, p<0.001). Collectively, these studies highlight miR-196b as a tumor suppressor whose silencing early in lung carcinogenesis may provide a selective growth advantage to pre-malignant cells. Targeted delivery of miR-196b could therefore serve as a preventive or therapeutic strategy for the management of lung cancer.
HBEC2MBT and H1975 were transiently transfected with a miR-196b mimic and subjected to array-based genome-wide gene expression profiling 48 hours post transfection.
 
Overall design Total RNA was isolated with TRIzol from transiently transfected cell lines 48 hours post transfection and subjected to bead array
 
Contributor(s) Tellez CS, Juri DE, Do K, Picchi MA, Wang T, Liu G, Spira A, Belinsky SA
Citation(s) 27302168
Submission date Apr 06, 2016
Last update date Sep 09, 2016
Contact name Carmen Tellez
E-mail(s) ctellez@lrri.org
Phone 505-348-9444
Organization name Lovelace Respiratory Research Institute
Street address 2425 Ridgecrest Dr. SE
City Albuquerque
State/province NM
ZIP/Postal code 87108
Country USA
 
Platforms (1)
GPL10904 Illumina HumanHT-12 V4.0 expression beadchip (gene symbol)
Samples (4)
GSM2109659 HBEC2MBT
GSM2109660 HBEC2MBT_miR-196b
GSM2109661 H1975
Relations
BioProject PRJNA317578

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE79987_non-normalization.txt.gz 2.1 Mb (ftp)(http) TXT
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap